Specializing in regulatory law for healthcare products, Anne’s practice focuses on legal issues affecting the healthcare, pharmaceutical, biotechnology and medtech sectors.
With over 25 years’ experience, Anne Servoir advises leading pharmaceutical companies, mid-sized enterprises, and start-ups in the pharmaceutical, biotech and medtech sectors, both in France and internationally.
She advises on all regulatory aspects relating to medicinal products—chemical and biological, for both human and veterinary use—as well as medical devices, food supplements, CBD-based products and cosmetics. She also assists on specific regulatory matters in relation with : advertising, transparency obligations, patient support programs and health data protection.
Anne advises clients at each step of their product’s life, from R&D to withdrawals. She assists medical devices manufacturers, originator companies, especially for advanced therapy medicines, in all aspects of their market access strategy: early access, compassionate use, transition to MA, final payback, reimbursement strategy, pricing negotiations. She also represent them in pre-litigation and litigation proceedings against decisions of regulatory authorities (including the ANSM and the CEPS).
In addition, Anne has been highly engaged in the field of medical cannabis since the launch of the pilot program in France.
Anne Servoir began her career in the Competition and European Law team at CMS Francis Lefebvre, where she developed extensive expertise in regulated sectors, from telecommunications to the pharmaceutical industry. She then joined Intuity, a firm specialising in pharmaceutical and regulatory law where she practised for nearly ten years. In 2017, she joined the Paris office of Hoyng Rokh Monegier, where she led the Regulatory Pharma practice.
Anne’s representative experience includes :
- assisting several innovator companies in relation to market access issues: early access, compassionate use, final payback, pricing and reimbursement strategy, assistance with the negotiation with the competent authorities
- supporting an originator firm in the definition of its filing strategy vis-à-vis the EMEA in order to obtain data protection (fixed combination, NAS statute, orphan indication, …)
- assisting an originator company in the definition of its litigation strategy in relation to the reimbursement of one of its products: preliminary injunction and appeal on the merits before the French Administrative Supreme Court (Conseil d’Etat)
- advising several companies, entering the French market for the first time, in order to ensure their compliance with the Transparency’s obligations and the provisions regulating, on the one hand, relationships between pharmaceutical firms, and on the other hand HCPs, Government Officials and patients’ groups. A practical handbook was prepared with the companies. Anne also provided a set of contract templates to be used in the various situations with each category of actors
- assistance to the members of the French sector in the development of medical cannabis, in particular in understanding and drawing up proposals for the drafting of the new regulatory framework
- assisting originator companies in the implementation and management of their Patient Support Programs
- developed and managed several supply chain management schemes at national and European level
- Litigated against the Competent Authorities’ decisions (MAs, withdrawals, ..) and in unfair competition cases / infringement of provisions ruling advertising in the pharmaceutical sector
- “CBD, une affaire française”, Journal de Droit de la Santé et de l’Assurance Maladie – Institut Droit et Santé – Nr 32, 2022
- Competition Law Analysis of Price and Non-price Discrimination & Abusive IP Based Legal Proceedings, France Chapter, LIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition, 2021, (co-author)
- Regular training sessions for IFIS
Anne Servoir is ranked in Legal 500 in the Healthcare and Life Sciences section:
- “Anne Servoir stands out due to her longstanding experience in competition matters within the pharma and biotech industries.” Legal 500 2025
- “Anne Servoir is incredibly knowledgeable in the regulatory space, and provides clear and practical advice for clients”. Legal 500 2022
- “Leading Individual" Legal 500 France, Healthcare And Life Sciences, 2021
- Licensing Executives Society (LES)
- Association Française d’Etude de la Concurrence (AFEC, membre de la LIDC)
- Admitted to the Paris Bar since 2000, Anne holds a PhD in European Law